Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR (N1VS34) Price & Analysis

― Followers

N1VS34 Stock Chart & Stats

R$79.68

-R$0.32(-0.40%)

Jul 31, 2026

―

Day’s Range― - ―

52-Week RangeR$0.01 - R$100.01

Previous CloseN/A

VolumeN/A

Average Volume (3M)98.00

Market Cap

R$1.46T

Enterprise ValueN/A

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta-0.03

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding2,034,819,500

10 Day Avg. Volume15

30 Day Avg. Volume98

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR News

Novartis says FDA approves Pluvicto for PSMA+ metastatic prostate cancer

Novartis (NVS) announced the US Food and Drug Administration approved Pluvicto in combination with an androgen receptor pathway...

2d ago

NVS

Novartis price target raised to CHF 142 from CHF 132 at Citi

Citi analyst Graham Parry raised the firm’s price target on Novartis (NVS) to CHF 142 from CHF 132...

11d ago

NVS

Trump Trade: U.S. to impose 100% tariff on imported generic drugs

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by...

11d ago

AAL

Novartis: Solid Fundamentals but Balanced Risk-Reward Justify Hold Rating

In a report released today, Shelby Tucker from TD Cowen maintained a Hold rating on Novartis AG, with...

6d ago

NVS

N1VS34 FAQ

What was Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR’s price range in the past 12 months?

Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR lowest stock price was R$0.01 and its highest was R$100.01 in the past 12 months.

What is Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR’s market cap?

Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR’s market cap is R$1.46T.

When is Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR’s earnings last quarter?

Currently, no data Available

Is Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR overvalued?

According to Wall Street analysts Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR pay dividends?

Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR does not currently pay dividends.

What is Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR’s EPS estimate?

Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR have?

Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR has 2,034,819,500 shares outstanding.

What happened to Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Novartis AG Unsponsored Brazilian Depositary Receipt Repr 0.1 ADR?

Currently, no hedge funds are holding shares in BR:N1VS34

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology